Recommendations for cyclin-dependent kinase 4/6 inhibitor treatments in the context of co-morbidity and drug interactions (Review)

Thumbnail Image

Tarih

2024

Yazarlar

Süreli Yayın başlığı

Süreli Yayın ISSN

Cilt Başlığı

ISSN

Cilt

Sayı

Yayınevi

SPANDIDOS PUBL LTD

Özet

Açıklama

Anahtar kelimeler

advanced breast cancer, comorbidity, cyclin\\-dependent kinase 4 and 6 inhibitors, safety, tolerability, toxicity

Alıntı

URI

https://openaccess.acibadem.edu.tr/handle/11443/5875

Koleksiyonlar

WOS

Endorsement

Review

Supplemented By

Referenced By